Does Rhonda Patrick recommend CoQ10 (Ubiquinol/Ubiquinone)?
Rhonda Patrick recommends CoQ10 (Ubiquinol/Ubiquinone) in some contexts, but has also raised cautions.
Published research rates it moderate evidence. Of Rhonda Patrick's 74 tracked claims, 27 are supported or partially supported by studies on PubMed.
Evidence last reviewed May 2026
Rhonda Patrick on CoQ10 (Ubiquinol/Ubiquinone) — 74 claims
“the Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.”
The Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.
None of the 10 retrieved studies correspond to the Q-SYMBIO trial or address CoQ10 supplementation in severe heart failure patients. The provided literature covers topics such as oocyte quality, ferti…
“the Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.”
The Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.
None of the 10 retrieved studies correspond to the Q-SYMBIO trial or directly address CoQ10 supplementation in severe heart failure populations. The provided literature covers topics such as oocyte qu…
“the Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.”
The Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.
None of the 10 provided research sources directly address the Q-SYMBIO trial or CoQ10 supplementation in heart failure patients. The provided literature covers topics such as CoQ10 in neurological dis…
“the Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.”
The Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.
None of the 10 published research entries provided include the Q-SYMBIO trial or any direct study on CoQ10 supplementation in heart failure patients. The available literature covers CoQ10 in contexts…
“the Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.”
The Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.
None of the 10 listed studies directly reference the Q-SYMBIO trial or provide specific findings about CoQ10 supplementation reducing major adverse cardiovascular events in heart failure patients. The…
“While the evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, the mechanistic rationale is sound.”
The evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, though the mechanistic rationale is sound.
The expert's claim is directly supported by the meta-analysis on CoQ10 and statin-induced myopathy (PMID: 30371340), which is a strong-quality updated meta-analysis of randomized controlled trials tha…
“the Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo. That's a striking result for a supplement and warrants serious attention”
The Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.
None of the 20 provided research summaries directly reference or describe the Q-SYMBIO trial by name or report its specific 43% reduction in major adverse cardiovascular events finding. PMID 37971634…
“the Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.”
The Q-SYMBIO trial showed that CoQ10 supplementation in patients with severe heart failure reduced major adverse cardiovascular events by 43% compared to placebo.
None of the 10 retrieved studies directly assess the Q-SYMBIO trial or CoQ10 supplementation in heart failure patients with major adverse cardiovascular events as an endpoint. The available literature…
“heart failure patients shouldn't change their medication without medical supervision.”
Heart failure patients should not change their medication without medical supervision, even given the striking Q-SYMBIO trial result.
None of the 10 provided studies directly address the Q-SYMBIO trial, heart failure management, or the specific caution about medication changes under medical supervision. The provided literature focus…
“While the evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, the mechanistic rationale is sound.”
The evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, though the mechanistic rationale is sound.
None of the 10 provided studies directly address CoQ10 supplementation for statin-induced myopathy. The retrieved literature covers CoQ10 in contexts such as oocyte quality, cardiovascular disease, mi…
“While the evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, the mechanistic rationale is sound.”
The evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, though the mechanistic rationale is sound.
The meta-analysis on CoQ10 and statin-induced myopathy (PMID: 30371340) directly addresses this claim, being an updated meta-analysis of randomized controlled trials that explicitly acknowledges uncer…
“heart failure patients shouldn't change their medication without medical supervision.”
Heart failure patients should not change their medication without medical supervision, even given the striking Q-SYMBIO trial result.
The expert's caution about not changing heart failure medication without medical supervision is clinically sound and aligns with the general tenor of the CoQ10 cardiovascular literature. The review on…
“While the evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, the mechanistic rationale is sound.”
The evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, though the mechanistic rationale is sound.
None of the 10 provided studies directly address CoQ10 supplementation for statin-induced myopathy (statin myopathy). The available literature covers CoQ10 in cardiovascular disease prevention, fertil…
“heart failure patients shouldn't change their medication without medical supervision.”
Heart failure patients should not change their medication without medical supervision, even given the striking Q-SYMBIO trial result.
None of the 10 provided studies directly address the Q-SYMBIO trial, heart failure management, or the specific caution about medication changes in heart failure patients. The available literature cove…
“While the evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, the mechanistic rationale is sound.”
The evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, though the mechanistic rationale is sound.
None of the 10 provided studies directly address CoQ10 supplementation for statin-induced myopathy. The retrieved literature focuses on fertility, cardiovascular disease, neurological conditions, and…
“While the evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, the mechanistic rationale is sound.”
The evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, though the mechanistic rationale is sound.
None of the 10 provided studies directly address CoQ10 supplementation for statin-induced myopathy (statin myopathy). The available literature covers CoQ10 in contexts such as cardiovascular disease p…
“While the evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, the mechanistic rationale is sound.”
The evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, though the mechanistic rationale is sound.
None of the 10 provided studies directly address CoQ10 supplementation for statin-induced myopathy (statin myopathy). The retrieved literature covers CoQ10 in contexts such as oocyte quality, cardiova…
“heart failure patients shouldn't change their medication without medical supervision.”
Heart failure patients should not change their medication without medical supervision, even given the striking Q-SYMBIO trial result.
None of the 10 provided studies address heart failure, the Q-SYMBIO trial, or medication management in cardiac patients. The provided literature focuses on fertility, ovarian aging, migraine prophylax…
“heart failure patients shouldn't change their medication without medical supervision.”
Heart failure patients should not change their medication without medical supervision, even given the striking Q-SYMBIO trial result.
None of the 10 provided studies directly address the Q-SYMBIO trial or the specific clinical guidance that heart failure patients should not alter medications without medical supervision. The listed l…
“While the evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, the mechanistic rationale is sound.”
The evidence that CoQ10 supplementation fully reverses statin myopathy is mixed, though the mechanistic rationale is sound.
None of the 10 provided studies directly address CoQ10 supplementation and statin-induced myopathy (statin myopathy). The retrieved literature covers CoQ10 in contexts such as oocyte quality, fertilit…
Other supplements Rhonda Patrick discusses
Claims are extracted from publicly available podcasts and videos, attributed to their source, and compared against PubMed research. This is educational information only — consult a healthcare provider before starting any supplement.
Back to Rhonda Patrick